We report the synthesis of ethylammonium lead iodide (EAPbI(3)) colloidal nanocrystals as another member of the lead halide perovskites family. The insertion of an unusually large A-cation (274 pm in diameter) in the perovskite structure, hitherto considered unlikely due to the unfavorable Goldschmidt tolerance factor, results in a significantly larger lattice parameter compared to the Cs-, methylammonium- and formamidinium-based lead halide perovskite homologues. As a consequence, EAPbI(3) nanocrystals are highly unstable, evolving to a nonperovskite δ-EAPbI(3) polymorph within 1 day. Also, EAPbI(3) nanocrystals are very sensitive to electron irradiation and quickly degrade to PbI(2) upon exposure to the electron beam, following a mechanism similar to that of other hybrid lead iodide perovskites (although degradation can be reduced by partially replacing the EA(+) ions with Cs(+) ions). Interestingly, in some cases during this degradation the formation of an epitaxial interface between (EA(x)Cs(1-x))PbI(3) and PbI(2) is observed. The photoluminescence emission of the EAPbI(3) perovskite nanocrystals, albeit being characterized by a low quantum yield (â¼1%), can be tuned in the 664-690 nm range by regulating their size during the synthesis. The emission efficiency can be improved upon partial alloying at the A site with Cs(+) or formamidinium cations. Furthermore, the morphology of the EAPbI(3) nanocrystals can be chosen to be either nanocube or nanoplatelet, depending on the synthesis conditions.
Breaking the Boundaries of the Goldschmidt Tolerance Factor with Ethylammonium Lead Iodide Perovskite Nanocrystals.
阅读:4
作者:Guvenc C Meric, Toso Stefano, Ivanov Yurii P, Saleh Gabriele, Balci Sinan, Divitini Giorgio, Manna Liberato
| 期刊: | ACS Nano | 影响因子: | 16.000 |
| 时间: | 2025 | 起止号: | 2025 Jan 14; 19(1):1557-1565 |
| doi: | 10.1021/acsnano.4c14536 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
